AstraZeneca PLC
1566.00
31-1月-25 11:29:40
15 分の遅延
株式
+10.00
+0.64%
本日の幅
1557.50 - 1572.00
ISIN
N/A
ソース
NASD.OMX SE
-
AstraZeneca : Canada Approves Ultomiris For Adults With Neuromyelitis Optica Spectrum Disorder
01 11 2023 07:46:39 提供 NASDAQ US Markets
-
Cellectis Announces Collaboration Agreement With AstraZeneca; To Receive Up To $245 Mln
01 11 2023 05:05:04 提供 NASDAQ US Markets
-
Here’s Why You Could Be Giving Yourself—Or Someone Else—A Flu Shot Next Year
24 10 2023 08:18:46 提供 Forbes - World
-
AstraZeneca : FDA Accepts For Review SBLA For Self-administration Of Flumist Quadrivalent
24 10 2023 07:49:37 提供 NASDAQ US Markets
-
AstraZeneca : Enhertu Approved In EU For Advanced Non-small Cell Lung Cancer Treatment
23 10 2023 03:05:09 提供 NASDAQ US Markets
-
AZN : Imfinzi Combination Reduces Risk Of Disease Progression Or Death By 45% In Endometrial Cancer
21 10 2023 11:33:24 提供 NASDAQ US Markets
-
AstraZeneca: 59% Of Patients Treated With Tagrisso + Chemotherapy Had Complete Brain Tumor Responses
21 10 2023 11:33:23 提供 NASDAQ US Markets
-
AstraZeneca: TAGRISSO Plus Chemotherapy Granted Priority Review By FDA
16 10 2023 07:36:08 提供 NASDAQ US Markets
-
Ascentage, AstraZeneca Collaborate On Phase III Study Of Lisaftoclax Combination In CLL/SLL
15 10 2023 23:53:04 提供 NASDAQ US Markets
-
AstraZeneca Settles Lawsuits Alleging Heartburn Drugs Caused Kidney Disease For $425 Million
03 10 2023 09:12:46 提供 Forbes - World